波士顿科学公司购买纳卢医疗公司533M元 增加无线神经刺激技术 治疗慢性疼痛 Boston Scientific to buy Nalu Medical for $533M to add wireless nerve stimulation tech for chronic pain.

波士顿科学公司将获得纳卢医疗公司5.33亿美元的现金,将无线无电池外围神经刺激系统加进慢性疼痛治疗中。 Boston Scientific will acquire Nalu Medical for $533 million in cash, adding its wireless, battery-free peripheral nerve stimulation system to its chronic pain treatments. 美国食品和药物管理局批准的技术用于肩膀,背部和膝盖疼痛,预计到2025年销售额将超过6000万美元,预计2026年将增长25%以上. The FDA-cleared technology, used for shoulder, back, and knee pain, is expected to generate over $60 million in 2025 sales with 25%+ growth projected for 2026. 这项交易在2026年初结束,对2026年的收入影响微乎其微,但此后将越来越有利。 The deal, closing in early 2026, will have minimal impact on earnings in 2026 but become increasingly accretive thereafter. 这一收购加强了波士顿科学公司的神经调控组合,补充了其现有的脊髓刺激和减缩疗法。 The acquisition strengthens Boston Scientific’s neuromodulation portfolio, complementing its existing spinal cord stimulation and ablation therapies. 在市场前贸易中,该公司的股票略有上升。 The company’s stock rose slightly in pre-market trading.